In 2022, the incidence rate of pancreatic cancer ranked 10th and the mortality rate ranked 6th among malignant tumors in China, according to a report released by the National Cancer Center in 2024 [1], with both incidence and mortality rates on an increasing trend [2,3]. Pancreatic cancer is extremely malignant and has an inferior prognosis, with a 5-year survival rate of less than 12% [4,5], which is much lower than that of malignant tumors in other organs. Currently, imaging diagnosis primaril…